ArticleClinical cancer research : an official journal of the American Association for Cancer Research2017

A Phase I Study of ABC294640, a First-in-Class Sphingosine Kinase-2 Inhibitor, in Patients with Advanced Solid Tumors.

Carolyn D Britten et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.